Insmed’s drug Brinsupri (brensocatib) has landed a double regulatory landmark win, becoming both the first marketed dipeptidyl peptidase 1 (DPP1) inhibitor and the first therapy for non-cystic ...

Our editorial team dives into the pharma industry's reaction to US tariffs on imports from the European Union and major ...

The breach was one of the largest reported cyberattack in insurance, as Allianz Life has around 1.4 million customers in the ...

The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200%-250% tariff on drug imports, which ...

Arena International has announced the launch of the GlobalData Automotive Europe Conference 2025, set to take place ...

South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.

Singapore-based HistoIndex has launched a new artificial intelligence (AI)-based laboratory developed test (LDT) in the US for measuring fibrosis in patients with metabolic dysfunction-associated ...

Greater China emerges as key player, driven by Hong Kong’s resurgence and "shifting global capital flows toward Chinese ...

The global IPO market displayed resilience in the first seven months of 2025, with proceeds rising 9.5% YoY to $56.8 billion: ...